Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

In the first episode of Weekly Dose, we dive into the most impactful clinical research from the past week on Patient Care, covering key studies across multiple specialties. We begin with a study on the treatment of bacterial vaginosis, highlighting the significant impact of antimicrobial therapy for male partners in reducing recurrence rates. Next, we explore a meta-analysis on the use of dupilumab in treating atopic dermatitis in children, showcasing its effectiveness in reducing disease severity and pruritus. We also cover a groundbreaking study on colorectal cancer risk models for adults aged under 45 years, introducing new ways to personalize screening strategies.

Additionally, we discuss the EKSTROM trial, which presents data on colchicine’s role in stabilizing coronary plaque and reducing cardiovascular risk. Finally, we look at the FDA’s approval of dupilumab for chronic spontaneous urticaria, offering new hope for patients with persistent symptoms despite antihistamine treatment.